The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.

BOSTON & MENLO PARK, Calif. & NEW YORK & LONDON, February 03, 2025--(BUSINESS WIRE)--Summit Partners, a leading growth-focused investment firm, today announced the promotion of eight professionals ...

The Pfizer company logo is displayed as traders work on the floor of the New York Stock Exchange during morning trading on April 10, 2023 in New York City.

(Bloomberg) -- Blackstone Inc. is in advanced talks to acquire vaccine management company VaxCare Corp. for about $1.7 billion including debt, according to people familiar with the matter.